Michael Tilson Thomas' brain tumor has returned, and the 80-year-old conductor intends to lead his final performance in April ...
Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas ...
Famed conductor and longtime director of the San Francisco Symphony Michael Tilson Thomas announced that his brain tumor has ...
The dark brown cockroach crawling up professor Agus Muñoz-Garcia’s right arm gives him no reason for worry. He grins as the creature makes its way toward his elbow, knowing the encounter is harmless.
A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled “Robust p53 phenotypes and ...
The FDA cleared the investigational new drug application for LTZ-301, a first-in-class myeloid engager immunotherapy, with a ...
Long-term yogurt consumption is associated with a reduced risk of Bifidobacterium-positive colorectal cancer, particularly in ...
In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumor DNA (ctDNA) may be critical. Researchers showed that absolute ctDNA concentration thresholds can be defined ...
Harvard biologist Mandë Holford studies venomous snails and other toxic creatures to unlock new medications that may one day ...
A cheerleading team in Butler County came together to comfort each other and pray for one of their team members, a ...
Michael Tilson Thomas, who led the San Francisco Symphony for 25 years, said, “Now is the time to wind down my public ...
A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood–brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results